SHARE:  

Nurses Present on the Need for Increased Education on a Particular Pancreatic Tumor Type at National Oncology Meeting

An insulinoma is a rare tumor that forms in the pancreas, which can cause a person’s blood sugar to drop to dangerously low levels. Kellie Zeichner BSN, RN, OCN; John Rodriguez BSN, RN, OCN; Yuk Wong MA, BSN, OCN and Donna Thomas BSN, RN, OCN, oncology nurses at Rutgers Cancer Institute recently presented a poster about enhancing education for the care of patients with insulinoma at the Oncology Nursing Society’s (ONS) Annual Congress, held recently in San Antonio. They share more about the importance of standardized monitoring procedures for patients with this kind of tumor. Read more

Exploring a Potential Therapeutic Approach to Acute Myeloid Leukemia

Acute myeloid leukemia (AML), the most common type of acute leukemia in adults, is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. Investigators further examined the mechanism behind BH3-mimetic drugs, which can help inform more effective therapies for this disease. Christina Glytsou, PhD, researcher and member of the Cancer Metabolism and Immunology Cancer Pharmacology Program at Rutgers Cancer Institute of New Jersey is co-author of the study. Learn more about the findings, which were recently published in Cancer Discovery: Read more

Addressing the Unique Mental Health Needs of Young People with Cancer 

Adolescents and young adults between the ages of 15 to 39 years old diagnosed with cancer may face many short and long-term health and psychosocial issues. To highlight Mental Health Awareness Month, Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey, shares the challenges and unique mental health needs of young people with cancer, and how they can find psychosocial support.  Read more

May is National Cancer Research Month  

To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research, is recognized during the month of May. As the state’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, is at the forefront of cancer research, addressing the demands of one of the most diverse and densely populated states in the nation. View recent research news and highlights From Rutgers Cancer InstituteView Here

As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
Join our Mailing List
Facebook  Twitter  Instagram  Linkedin  Youtube